Clinical Trial Update: Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temozolomide followed by nivolumab for colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Temozolomide (Temozolomide)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: WITHDRAWN